China-focused infant formula firm Synutra International has cut its full-year sales and profits guidance following a weaker-than-expected first quarter.
For the three months to the end of June, Synutra saw net sales rise by 22.5% to US$53.6m. However, the group still lowered its full-year sales outlook to a range of $380m to $400m, versus a previous range of $400m to $420m. Net sales hit $342m in the firm’s previous fiscal year.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Synutra blamed the weaker-than-expected first-quarter sales on distributors stocking up on its products in the final quarter of the previous year, in order to avoid a planned price increase.
The group also cut its net profit forecast for its current fiscal year, to between $50m and $57m versus a predicted range of $55m to $65m previously. In the first quarter, the group remained in the red, with net losses deepening by 3.5% to almost $9.8m.
Synutra chairman and CEO Liang Zhang said: “Although we are working through a challenging period in the fiscal first half, we continue to be encouraged with our opportunities in the second half of our fiscal year.”
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
